BioSpace News Archive

FDA

Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis

The approval is based on the Phase III UNIFI study that showed that after eight weeks of taking a single intravenous dose of Stelara, patients saw “clinical remission in a significantly greater proportion of UC patients.”

October 21, 2019
·
2 min read
·
Alex Keown
Policy

Teva and 3 Drug Distributors Settle Opioid Lawsuits in Ohio Ahead of Trial

As an historic lawsuit over opioids was to enter court today, four key defendants reached a settlement.

October 21, 2019
·
3 min read
·
Mark Terry
Business

Generational Priorities: What Baby Boomers, Gen-Xers and Millennials Think Makes an Ideal Employer

When it comes to specific attributes, having the opportunity to do interesting and meaningful work, securing a competitive salary and having access to quality health benefits were the most important. Here are some differences when it comes to generational priorities.

October 21, 2019
·
3 min read
·
Porschia Parker
Brexit Pharma Updates

Several events relevant to UK pharma have occurred recently. Here’s a look.

October 21, 2019
·
2 min read
·
Gina Hagler
Policy

Singapore Completes World’s Largest Whole Genome Sequencing Analysis Of Multi-Ethnic Asian Populations

Comprehensive genomic information of largely understudied Asian populations will expand understanding on the biology of diseases

October 21, 2019
·
6 min read
New polysomnography electrode set enables easy at-home assessment of sleep bruxism

An easy-to-use electrode set can assess sleep bruxism severity as well as a conventional polysomnography, a new study from the University of Eastern Finland shows

October 21, 2019
·
4 min read
Gut health testing biotech Microba wins 2019 Lord Mayor’s Innovation Award

Brisbane-based world leaders in metagenomic testing, Microba, have won the 2019 Product Innovation Award at the Lord Mayor’s Awards Dinner tonight

October 21, 2019
·
2 min read
Business

Promore Pharma engages ABG Sundal Collier as liquidity provider

Promore Pharma AB announced that the company has entered into an agreement with ABG Sundal Collier ASA whereby ABGSC will act as liquidity provider for the Promore Pharma share starting 21 October.

October 21, 2019
·
1 min read
Policy

Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA

Santhera Pharmaceuticals announces that the UK’s Medicines and Healthcare Products Regulatory Agency has informed ReveraGen BioPharma about having designated vamorolone as Promising Innovative Medicine for the treatment of Duchenne muscular dystrophy

October 21, 2019
·
5 min read
BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable Syringe in One Integrated System

New solution supports injection of different viscosities and volumes without the need for system customization

October 21, 2019
·
3 min read